News & Views
IMRT System delivers First Treatment in India
Oct 26 2018 Read 620 Times
Sterling Cancer Hospital in Gujarat, has treated the first patient in India with Varian’s Halcyon, an image-guided volumetric intensity-modulated radiotherapy (IMRT) system, for treatments of lung, prostate, breast, head & neck and many other forms of cancer.
"The high-quality Cone Beam CT images, the simplified workflow and the fast treatment delivery speed of the Halcyon system have made a very positive impact on our team and their ability to deliver advanced treatments," said Arun Shiva Balasubramanian, general manager, corporate head Medical Physics of Sterling Group. "The fast delivery time ensures that the patient is more comfortable, intra-fraction movement is minimised and hence setting a new standard in the precision of radiation therapy delivery."
"Halcyon was designed to deliver high-quality treatments and empower clinicians to care for more patients," said Ashok Kakkar, senior managing director, Varian India. "We are very pleased Sterling Cancer Hospital has now begun treating patients on the system and we look forward to our continued partnership with them to help increase access to cancer care across India."
Halcyon features a streamlined workflow that only requires nine steps from the start to the end of treatment compared to up to more than 30 steps with older technologies. To assist in the reduction of time and construction costs from installation to first patient treatment, Halcyon offers expedited commissioning, requires less shielding than traditional systems, can fit in the majority of existing small vaults and can be installed in two weeks or less.
Halcyon received Atomic Energy Regulatory Board (AERB) Certificate for Import and Supply in India in February this year and in July the system received Type Approval.
Do you like or dislike what you have read? Why not post a comment to tell others / the manufacturer and our Editor what you think. To leave comments please complete the form below. Providing the content is approved, your comment will be on screen in less than 24 hours. Leaving comments on product information and articles can assist with future editorial and article content. Post questions, thoughts or simply whether you like the content.
In This Edition Mass Spectrometry & Spectroscopy - Translating Proteomic MALDi Tissue Typing to Clinical Pathology - Fusion Protein Complexes Analysed by CG-MALS - Non-equivalent, Multivalen...
View all digital editions
Dec 13 2019 Kathmandu, Nepal
Jan 25 2020 San Diego, CA, USA
Jan 27 2020 Dubai, UAE
Jan 29 2020 Tokyo, Japan
Jan 29 2020 Ghent, Belgium